Biotech & Health
AI Accelerates Whole Body Rejuvenation Drug Discovery for Healthspan
David Sinclair plans to launch human tests of an oral 'reprogramming' drug as part of a $101 million XPrize competition, according to MIT Technology Review .
Lena Petrova·June 10, 2026
